세계의 보청기 시장 : 제품별, 난청 유형별, 환자 유형별, 기술별, 유통 채널별, 지역별 - 예측(-2030년)

The global hearing aids market is projected to reach USD 14.42 billion by 2030 from USD 10.35 billion in 2025, at a CAGR of 6.8% during the forecast period.

The large growth in the hearing aids market is due to the increasing prevalence of hearing loss, the rising aging population, and growing awareness of hearing-related disorders, which drive market growth. Additionally, the increasing adoption of smart and user-friendly digital hearing aids is expected to further support market expansion.

"Audiology and ENT hospitals & clinics are the leading distribution channel in the hearing aids market."

The hearing aids market is delineated by distribution channels, specifically categorized into audiology and ENT hospitals and clinics, retail and pharmacy outlets, and online platforms. In 2024, hospitals and clinics commanded the largest market share. These institutions provide a comprehensive continuum of hearing healthcare, encompassing diagnosis, device fitting, and post-fitting management, which is particularly critical for individuals with progressive or complex hearing impairments. The established trust in these facilities significantly enhances adoption rates. Audiology and ENT hospitals & clinics are typically staffed with qualified specialists and are equipped with soundproof testing environments, diagnostic apparatus, and surgical capabilities. They deliver non-surgical solutions and implantable hearing devices within a single location, streamlining the patient's experience. Research indicates that optimized clinical frameworks-such as unbundled pricing models-further facilitate increased uptake of hearing aids. These healthcare settings remain preeminent in the market due to their ability to provide precise diagnostics, professional counsel, and integrated services for hearing aids and implantable devices.

"Digital hearing commanded the largest share in the hearing aids technology market in 2024."

The global hearing aids market categorizes devices into digital and analog hearing aids. As of 2024, digital hearing aids accounted for the largest market share owing to their superior functionalities, including enhanced speech intelligibility and adaptive sound processing capabilities. These devices convert ambient noise into digital signals, which are then processed using sophisticated algorithms to optimize auditory perception, suppress unwanted background noise, and reduce acoustic feedback-features that are notably absent in traditional analog hearing aids. Digital hearing aids are predominantly prescribed by audiologists in clinical settings such as hospitals and specialized hearing care facilities. A significant number of contemporary models are equipped with wireless connectivity, allowing for remote adjustment and automatic adaptation to varying acoustic environments, thereby improving user convenience and overall experience. Meanwhile, analog hearing aids are experiencing a gradual decline in market presence; they remain primarily in use in low-cost settings, particularly in rural or infrastructure-limited regions of low- and middle-income countries, where access to digital technology and fitting services is restricted.

"Asia Pacific is expected to be the fastest-growing region of the hearing aids regional market during the study period."

The global hearing aids market is categorized into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is witnessing rapid expansion, driven by a significant increase in the elderly demographic, heightened demand for otolaryngological services, and substantial investments in healthcare infrastructure. This region presents considerable growth potential for industry stakeholders and is anticipated to achieve the highest compound annual growth rate (CAGR) during the forecast period. As demographic aging progresses, nations such as South Korea, Taiwan, and Singapore observe a rising prevalence of hearing loss, escalating the demand for audiological care. Government initiatives aimed at enhancing healthcare access and expanding hospital and clinic networks have made hearing aids more accessible to the population. Furthermore, the region's burgeoning medical tourism sector, particularly in Thailand and Malaysia, is facilitating an increase in the availability and adoption of hearing care solutions. These trends are expected to sustain robust market growth across the Asia Pacific region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1: 38%, Tier 2: 29%, and Tier 3: 33%
• By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
• By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3%

Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the hearing aids market are Sonova (Switzerland), Demant A/S(Denmark), GN Store Nord A/S (Denmark), Cochlear Ltd. (Australia), Rion Co., Ltd. (Japan), Eargo Inc. (US), Starkey Laboratories, Inc. (US), WSAudiology (Denmark), Zhejiang Nurotron Biotechnology Co., Ltd. (China), and MED-EL Medical Electronics (Austria), among others.

Research Coverage

This report examines the hearing aids market based on product type, type of hearing loss, patient type, technology, distribution channel, and region. It also explores factors such as drivers, restraints, opportunities, and challenges that influence market growth, and provides details on the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of market segments across five major regions and their respective countries.

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights on the following pointers:

• Analysis of key drivers (increasing global burden of hearing loss, increase in aging population, supportive insurance coverage and expanding reimbursement access, increasing adoption of smart hearing aids amid rising noise-induced hearing loss), restraints (high cost of hearing aids and associated treatments, risks, accessibility, and long post-surgery rehabilitation associated with hearing aid), opportunities (high-growth potential for hearing technologies in emerging economies, integration with digital health platforms enhances hearing device care), and challenges (shortage of skilled professionals performing ENT Procedures).
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the hearing aids market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the hearing aids market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the hearing aids market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 Approach 3: Primary interviews
    • 2.2.1.4 Growth forecast
    • 2.2.1.5 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 STUDY-RELATED ASSUMPTIONS
  • 2.4.2 PARAMETRIC ASSUMPTIONS
  • 2.4.3 GROWTH RATE ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 HEARING AIDS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: HEARING AIDS CARE MARKET SHARE, BY DISTRIBUTION CHANNEL AND COUNTRY
• 4.3 HEARING AIDS MARKET, BY KEY COUNTRY
• 4.4 HEARING AIDS MARKET, REGIONAL MIX

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increase in global burden of hearing loss
    • 5.2.1.2 Increase in aging population
    • 5.2.1.3 Supportive insurance coverage and expanding reimbursement access
    • 5.2.1.4 Increase in adoption of smart hearing aids amid rising noise-induced hearing loss
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of hearing aids and associated treatments
    • 5.2.2.2 Risks, accessibility, and long post-surgery rehabilitation associated with hearing aids
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High-growth potential for hearing technologies in emerging economies
    • 5.2.3.2 Integration with digital health platforms to enhance hearing device care
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of skilled professionals performing ENT procedures
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE TREND OF HEARING AID PRODUCTS, BY REGION
  • 5.3.2 AVERAGE SELLING PRICE TREND OF HEARING AID PRODUCTS, BY KEY PLAYER
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 BARGAINING POWER OF SUPPLIERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.8.2 KEY BUYING CRITERIA
• 5.9 REGULATORY ANALYSIS
  • 5.9.1 REGULATORY FRAMEWORK
    • 5.9.1.1 North America
      • 5.9.1.1.1 US
      • 5.9.1.1.2 Canada
    • 5.9.1.2 Europe
    • 5.9.1.3 Asia Pacific
      • 5.9.1.3.1 Japan
      • 5.9.1.3.2 China
      • 5.9.1.3.3 India
    • 5.9.1.4 Latin America
      • 5.9.1.4.1 Brazil
      • 5.9.1.4.2 Mexico
    • 5.9.1.5 Middle East
    • 5.9.1.6 Africa
  • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA (HS CODE 902140)
  • 5.10.2 EXPORT DATA (HS CODE 902140)
• 5.11 PATENT ANALYSIS
  • 5.11.1 LIST OF MAJOR PATENTS
• 5.12 KEY CONFERENCES & EVENTS
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 TECHNOLOGY ANALYSIS
  • 5.14.1 KEY TECHNOLOGIES
    • 5.14.1.1 Digital signal processing (DSP)
  • 5.14.2 COMPLEMENTARY TECHNOLOGIES
    • 5.14.2.1 Bimodal hearing solutions
  • 5.14.3 ADJACENT TECHNOLOGIES
    • 5.14.3.1 Cochlear implants & bone-anchored hearing systems
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 IMPACT OF AI/GEN AI ON COCHLEAR IMPLANTS MARKET
• 5.17 CASE STUDY ANALYSIS
  • 5.17.1 ADVANCING HEARING CAPABILITY WITH INTEGRATED COCHLEAR IMPLANT AND HEARING AID TECHNOLOGY
  • 5.17.2 WIDEX MOMENT EXPERIENCE: RESTORING SOUND PRECISION THROUGH ADVANCED HEARING TECHNOLOGY
  • 5.17.3 NANCY E. AND BAHA SYSTEM: REDISCOVERING SOUND AFTER FIVE DECADES
• 5.18 IMPACT OF AI ON HEARING AIDS MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 MARKET POTENTIAL OF AI IN HEARING AIDS MARKET
  • 5.18.3 AI USE CASES
  • 5.18.4 KEY COMPANIES IMPLEMENTING AI
  • 5.18.5 FUTURE OF AI IN HEARING AIDS MARKET
• 5.19 IMPACT OF US TARIFF REGULATION ON HEARING AIDS MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
  • 5.19.4 KEY IMPACTS ON COUNTRY/REGION
    • 5.19.4.1 North America
    • 5.19.4.2 Europe
    • 5.19.4.3 Asia Pacific
  • 5.19.5 IMPACT ON END-USE INDUSTRIES
    • 5.19.5.1 Audiology and ENT hospitals & clinics

6 HEARING AIDS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 HEARING AID DEVICES
  • 6.2.1 RECEIVER-IN-THE-EAR HEARING AIDS
    • 6.2.1.1 Designed to manage mild to severe hearing loss
  • 6.2.2 BEHIND-THE-EAR HEARING AIDS
    • 6.2.2.1 Affordability and advancements in BTE hearing aids to drive growth
  • 6.2.3 CANAL HEARING AIDS
    • 6.2.3.1 Technological innovations and low visibility to drive demand for canal aids
  • 6.2.4 IN-THE-EAR HEARING AIDS
    • 6.2.4.1 Custom fit and advanced functionality of ITE hearing aids to drive market expansion
  • 6.2.5 OTHER HEARING AID DEVICES
• 6.3 HEARING IMPLANTS
  • 6.3.1 COCHLEAR IMPLANTS
    • 6.3.1.1 Cochlear implants to lead hearing implants market
  • 6.3.2 BONE-ANCHORED SYSTEMS
    • 6.3.2.1 Rise in adoption of bone-anchored hearing systems in single-sided deafness and conductive hearing loss

7 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS

• 7.1 INTRODUCTION
• 7.2 SENSORINEURAL HEARING LOSS
  • 7.2.1 GROWTH OF ELDERLY POPULATION TO DRIVE SENSORINEURAL HEARING LOSS SEGMENT
• 7.3 CONDUCTIVE HEARING LOSS
  • 7.3.1 TECHNOLOGICAL INNOVATIONS AND REGULATORY APPROVALS TO FUEL GROWTH OF CONDUCTIVE HEARING LOSS SEGMENT

8 HEARING AIDS MARKET, BY PATIENT TYPE

• 8.1 INTRODUCTION
• 8.2 ADULTS
  • 8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS MAKES ADULTS KEY SEGMENT OF OVERALL PATIENT POOL
• 8.3 PEDIATRICS
  • 8.3.1 TECHNOLOGICAL ADVANCEMENTS TO FUEL GROWTH OF PEDIATRIC HEARING AIDS

9 HEARING AIDS MARKET, BY TECHNOLOGY

• 9.1 INTRODUCTION
• 9.2 DIGITAL
  • 9.2.1 PRECISION SOUND TAILORED THROUGH DIGITAL PROCESSING TO PROPEL MARKET
• 9.3 ANALOG
  • 9.3.1 ANALOG: AFFORDABLE SOLUTIONS FOR BASIC HEARING NEEDS

10 HEARING AIDS MARKET, BY DISTRIBUTION CHANNEL

• 10.1 INTRODUCTION
• 10.2 AUDIOLOGY AND ENT HOSPITALS & CLINICS
  • 10.2.1 EXPERT-LED CARE IN CLINICAL SETTINGS TO DRIVE HIGHER ADOPTION AND SATISFACTION
• 10.3 RETAIL & PHARMACY STORES
  • 10.3.1 EXPANDING ACCESS TO HEARING CARE THROUGH CONVENIENT AND AFFORDABLE IN-STORE OPTIONS
• 10.4 ONLINE SALES
  • 10.4.1 EMERGING CHANNEL OFFERING REMOTE ACCESS TO HEARING AIDS

11 HEARING AIDS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 US to lead North America's hearing aids market through 2030
  • 11.2.3 CANADA
    • 11.2.3.1 Targeted awareness-raising and aging trends to drive steady growth in Canada's hearing aids market
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Growth in healthcare expenditure in Germany to drive demand for advanced hearing aids
  • 11.3.3 UK
    • 11.3.3.1 Rise in burden of hearing loss continues to fuel market expansion in UK
  • 11.3.4 FRANCE
    • 11.3.4.1 Investment in R&D and technological innovation to drive market expansion in France
  • 11.3.5 SPAIN
    • 11.3.5.1 Rise in life expectancy and aging population to boost market growth
  • 11.3.6 ITALY
    • 11.3.6.1 Rise in Italy's elderly population to create further potential demand for hearing aids
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 China to continue dominating Asia Pacific hearing aids market
  • 11.4.3 INDIA
    • 11.4.3.1 Healthcare infrastructure improvements to drive hearing aids market growth
  • 11.4.4 JAPAN
    • 11.4.4.1 Aging population and favorable insurance policies to support adoption in Japan
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 Rise in geriatric population and government programs to accelerate market growth
  • 11.4.6 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Largest healthcare sector in region and government initiatives to drive market
  • 11.5.3 MEXICO
    • 11.5.3.1 Expanding hospital infrastructure to support hearing healthcare growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
• 12.3 REVENUE ANALYSIS, 2022-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Regional footprint
    • 12.5.5.3 Product footprint
    • 12.5.5.4 Type of hearing loss footprint
    • 12.5.5.5 Patient type footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 12.6.5.1 Detailed list of key startups/SMEs
    • 12.6.5.2 Competitive benchmarking of key startups/SMEs
• 12.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.7.1 COMPANY VALUATION
  • 12.7.2 FINANCIAL METRICS
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES & APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS
  • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 SONOVA
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches & approvals
      • 13.1.1.3.2 Deals
      • 13.1.1.3.3 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 WSAUDIOLOGY
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches & approvals
      • 13.1.2.3.2 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 DEMANT A/S
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches & approvals
      • 13.1.3.3.2 Deals
      • 13.1.3.3.3 Expansions
      • 13.1.3.3.4 Other developments
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 COCHLEAR LTD.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches & approvals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 GN STORE NORD A/S
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches & approvals
      • 13.1.5.3.2 Deals
      • 13.1.5.3.3 Other developments
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 STARKEY LABORATORIES, INC.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches & approvals
      • 13.1.6.3.2 Deals
  • 13.1.7 MED-EL MEDICAL ELECTRONICS
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Deals
  • 13.1.8 EARGO INC.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
  • 13.1.9 RION CO., LTD.
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Deals
  • 13.1.10 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
• 13.2 OTHER PLAYERS
  • 13.2.1 AUDINA HEARING INSTRUMENTS, INC.
  • 13.2.2 NEUBIO AG
  • 13.2.3 HORENTEK HEARING DIAGNOSTICS
  • 13.2.4 SEBOTEK HEARING SYSTEMS, LLC
  • 13.2.5 ARPHI ELECTRONICS PRIVATE LIMITED
  • 13.2.6 IN4 TECHNOLOGY CORPORATION
  • 13.2.7 AUDICUS
  • 13.2.8 NANO HEARING AIDS
  • 13.2.9 LORECA HEARING AID
  • 13.2.10 EARLENS CORP.
  • 13.2.11 AUSTAR HEARING SCIENCE AND TECHNOLOGY (XIAMEN) CO., LTD.
  • 13.2.12 SHANGHAI LISTENT MEDICAL TECH CO., LTD.
  • 13.2.13 AUDIFON GMBH & CO. KG
  • 13.2.14 FOSHAN VOHOM TECHNOLOGY CO., LTD.
  • 13.2.15 TODOC CO., LTD.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS